Evaluating glucose variability through OGTT in early pregnancy and its association with hypertensive disorders of pregnancy in non-diabetic pregnancies: a large-scale multi-center retrospective study.
Glucose variability
Hypertensive disorders of pregnancy
OGTT
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
09 Jun 2023
09 Jun 2023
Historique:
received:
16
12
2022
accepted:
31
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
9
6
2023
Statut:
epublish
Résumé
Recent evidence suggests increased glucose variability (GV) causes endothelial dysfunction, a central pathology of hypertensive disorders of pregnancy (HDP). We aimed to investigate the association between GV in early pregnancy and subsequent HDP development among non-diabetes mellitus (DM) pregnancies. This multicenter retrospective study used data from singleton pregnancies between 2009 and 2019. Among individuals who had 75 g-OGTT before 20 weeks of gestation, we evaluated GV by 75 g-OGTT parameters and examined its relationship with HDP development, defining an initial-increase from fasting-plasma glucose (PG) to 1-h-PG and subsequent-decrease from 1-h-PG to 2-h-PG. Approximately 3.0% pregnancies (802/26,995) had 75 g-OGTT before 20 weeks of gestation, and they had a higher prevalence of HDP (14.3% vs. 7.5%). The initial-increase was significantly associated with overall HDP (aOR 1.20, 95% CI 1.02-1.42), and the subsequent-decrease was associated with decreased and increased development of early-onset (EoHDP: aOR 0.56, 95% CI 0.38-0.82) and late-onset HDP (LoHDP: aOR 1.38, 95% CI 1.11-1.73), respectively. A pattern of marked initial-increase and minor subsequent-decrease (i.e., sustained hyperglycemia) was associated with EoHDP. Contrarily, the pattern of marked initial-increase and subsequent-decrease (i.e., increased GV) was associated with LoHDP. This provides a new perspective for future study strategies.
Sections du résumé
BACKGROUND
BACKGROUND
Recent evidence suggests increased glucose variability (GV) causes endothelial dysfunction, a central pathology of hypertensive disorders of pregnancy (HDP). We aimed to investigate the association between GV in early pregnancy and subsequent HDP development among non-diabetes mellitus (DM) pregnancies.
METHODS
METHODS
This multicenter retrospective study used data from singleton pregnancies between 2009 and 2019. Among individuals who had 75 g-OGTT before 20 weeks of gestation, we evaluated GV by 75 g-OGTT parameters and examined its relationship with HDP development, defining an initial-increase from fasting-plasma glucose (PG) to 1-h-PG and subsequent-decrease from 1-h-PG to 2-h-PG.
RESULTS
RESULTS
Approximately 3.0% pregnancies (802/26,995) had 75 g-OGTT before 20 weeks of gestation, and they had a higher prevalence of HDP (14.3% vs. 7.5%). The initial-increase was significantly associated with overall HDP (aOR 1.20, 95% CI 1.02-1.42), and the subsequent-decrease was associated with decreased and increased development of early-onset (EoHDP: aOR 0.56, 95% CI 0.38-0.82) and late-onset HDP (LoHDP: aOR 1.38, 95% CI 1.11-1.73), respectively.
CONCLUSIONS
CONCLUSIONS
A pattern of marked initial-increase and minor subsequent-decrease (i.e., sustained hyperglycemia) was associated with EoHDP. Contrarily, the pattern of marked initial-increase and subsequent-decrease (i.e., increased GV) was associated with LoHDP. This provides a new perspective for future study strategies.
Identifiants
pubmed: 37296464
doi: 10.1186/s13098-023-01103-z
pii: 10.1186/s13098-023-01103-z
pmc: PMC10251636
doi:
Types de publication
Journal Article
Langues
eng
Pagination
123Informations de copyright
© 2023. The Author(s).
Références
Int J Mol Sci. 2021 Jul 21;22(15):
pubmed: 34360550
Int J Mol Sci. 2021 Oct 12;22(20):
pubmed: 34681648
J Diabetes Complications. 2015 Apr;29(3):395-9
pubmed: 25681043
Diabetes. 2003 Nov;52(11):2795-804
pubmed: 14578299
JAMA. 2006 Apr 12;295(14):1681-7
pubmed: 16609090
BMJ Open. 2019 May 5;9(5):e023014
pubmed: 31061012
Diabetes. 2008 May;57(5):1349-54
pubmed: 18299315
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Obstet Gynecol. 2009 Nov;114(5):1076-1084
pubmed: 20168110
J Diabetes Investig. 2021 Nov;12(11):2071-2079
pubmed: 33960705
Hypertension. 2022 Feb;79(2):e21-e41
pubmed: 34905954
J Matern Fetal Neonatal Med. 2022 Dec;35(25):9639-9646
pubmed: 35264056
Circulation. 2002 Oct 15;106(16):2067-72
pubmed: 12379575
Placenta. 2009 Mar;30 Suppl A:S32-7
pubmed: 19070896
Diabetes Care. 2016 Jan;39(1):75-81
pubmed: 26645084
Diabetes. 2012 Mar;61(3):708-15
pubmed: 22315308
Pregnancy Hypertens. 2013 Jan;3(1):44-7
pubmed: 26105740
Diabetes Obes Metab. 2009 Mar;11(3):213-22
pubmed: 18564177
J Diabetes Res. 2020 Oct 12;2020:7489795
pubmed: 33123598
Endocrinol Metab Clin North Am. 2019 Sep;48(3):511-531
pubmed: 31345520
Diabetes Care. 2011 Jul;34(7):1605-9
pubmed: 21610126
Am J Obstet Gynecol. 2010 Mar;202(3):255.e1-7
pubmed: 20207245
Diabetes Res Clin Pract. 2019 Aug;154:75-81
pubmed: 31271810
Diabetes Res Clin Pract. 2022 Nov;193:110117
pubmed: 36243232
Diabetologia. 2011 May;54(5):1219-26
pubmed: 21287141
Diabetes Technol Ther. 2020 May;22(5):395-403
pubmed: 31886732
Sci Rep. 2021 Nov 18;11(1):22519
pubmed: 34795378
Fertil Steril. 2019 Mar;111(3):489-496.e5
pubmed: 30709546
Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E924-30
pubmed: 11595647
Reprod Sci. 2009 Oct;16(10):995-1000
pubmed: 19564642
Am J Obstet Gynecol. 1995 Jul;173(1):146-56
pubmed: 7631672
Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119
pubmed: 32835720
JAMA. 2021 Aug 10;326(6):531-538
pubmed: 34374716
Diabetes Metab Syndr Obes. 2021 Jul 05;14:3047-3076
pubmed: 34262311
PLoS Med. 2013;10(4):e1001425
pubmed: 23610560
Diabetes Technol Ther. 2021 Nov;23(11):768-772
pubmed: 34115946
J Obstet Gynaecol Res. 2020 Sep;46(9):1690-1701
pubmed: 32512641
Am J Obstet Gynecol. 2004 Nov;191(5):1655-60
pubmed: 15547538
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
J Obstet Gynaecol Res. 2023 Jan;49(1):5-53
pubmed: 36251613
J Endocr Soc. 2018 May 07;2(6):547-562
pubmed: 29942919
Diabetes Res Clin Pract. 2021 Apr;174:108736
pubmed: 33705819
Pediatr Int. 2014 Oct;56(5):702-8
pubmed: 24617834
Clin Endocrinol (Oxf). 2017 Nov;87(5):484-491
pubmed: 28681942
Diabetol Int. 2017 Sep 04;9(2):113-120
pubmed: 30603358
Front Endocrinol (Lausanne). 2020 Mar 17;11:135
pubmed: 32256449
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363
Obstet Gynecol. 2018 Aug;132(2):496-505
pubmed: 29995731
N Engl J Med. 2008 Aug 21;359(8):800-9
pubmed: 18716297
J Clin Endocrinol Metab. 2005 Aug;90(8):4846-51
pubmed: 15886249